These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15767620)

  • 1. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
    Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
    Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and the risk of incident colorectal cancer.
    Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
    JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Can a blood test help predict who is at risk for colorectal cancer?
    Ann Intern Med; 2005 Mar; 142(6):I79. PubMed ID: 15767616
    [No Abstract]   [Full Text] [Related]  

  • 4. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
    Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
    Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
    Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
    Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
    Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
    Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Bueno-de-Mesquita HB; Jansen EH; Tsilidis KK; Trichopoulou A; Weiderpass E; Wu C; Overvad K; Tjønneland A; Boutron-Ruault MC; Dossus L; Racine A; Kaaks R; Canzian F; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Johansson A; Van Guelpen B; Khaw KT; Wareham N; Peeters PH; Quirós JR; Venceslá García A; Molina-Montes E; Dorronsoro M; Chirlaque MD; Barricarte Gurrea A; Key TJ; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E; Pischon T
    Int J Cancer; 2015 Mar; 136(5):1181-92. PubMed ID: 25043606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.
    Pirro M; Bergeron J; Dagenais GR; Bernard PM; Cantin B; Després JP; Lamarche B
    Arch Intern Med; 2001 Nov; 161(20):2474-80. PubMed ID: 11700160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
    Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
    Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
    Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
    JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
    Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
    J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
    Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
    PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is C-reactive protein specific for vascular disease in women?
    Rifai N; Buring JE; Lee IM; Manson JE; Ridker PM
    Ann Intern Med; 2002 Apr; 136(7):529-33. PubMed ID: 11926788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
    Prizment AE; Anderson KE; Visvanathan K; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
    Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
    Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and risk for colorectal cancer.
    Mascitelli L; Pezzetta F
    Ann Intern Med; 2005 Oct; 143(7):544; author reply 544. PubMed ID: 16204172
    [No Abstract]   [Full Text] [Related]  

  • 17. [C-reactive protein level and colorectal adenoma].
    Park SK; Park DI; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim JE; Son HJ
    Korean J Gastroenterol; 2008 Apr; 51(4):225-31. PubMed ID: 18516001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
    Arnold LW; Hoy WE; Wang Z
    Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of C-reactive protein levels and colorectal adenoma development.
    Gunter MJ; Cross AJ; Huang WY; Stanczyk FZ; Purdue M; Xue X; Schoen R; Limburg PJ; Schatzkin A; Sinha R; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):537-44. PubMed ID: 21212059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and fracture risk: European prospective investigation into Cancer Norfolk Study.
    Ahmadi-Abhari S; Luben RN; Wareham NJ; Khaw KT
    Bone; 2013 Sep; 56(1):67-72. PubMed ID: 23702388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.